You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Moodys
McKesson
Express Scripts
Dow

Last Updated: October 3, 2023

Investigational Drug Information for D-glucose


✉ Email this page to a colleague

« Back to Dashboard


What is the development status for investigational drug D-glucose?

D-glucose is an investigational drug.

There have been 48 clinical trials for D-glucose. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2021.

The most common disease conditions in clinical trials are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, and Carcinoma. The leading clinical trial sponsors are National Cancer Institute (NCI), University of Pennsylvania, and M.D. Anderson Cancer Center.

There are thirteen US patents protecting this investigational drug and six hundred and fifty-one international patents.

Recent Clinical Trials for D-glucose
TitleSponsorPhase
Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT TrialECOG-ACRIN Cancer Research GroupPhase 2
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and NivolumabNational Cancer Institute (NCI)Phase 3
Pancreatic Clamp in NAFLDAlbert Einstein College of MedicinePhase 1

See all D-glucose clinical trials

Clinical Trial Summary for D-glucose

Top disease conditions for D-glucose
Top clinical trial sponsors for D-glucose

See all D-glucose clinical trials

US Patents for D-glucose

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
D-glucose ⤷  Try a Trial Cancerous B cell treatment using substituted nucleoside derivatives The Scripps Research Institute (La Jolla, CA) ⤷  Try a Trial
D-glucose ⤷  Try a Trial Adhesive base material Kowa Co., Ltd. (Nagoya, JP) ⤷  Try a Trial
D-glucose ⤷  Try a Trial Purified mite allergen Fumakilla Ltd. (Tokyo, JP) Hiroshima University (Hiroshima-Ken, JP) ⤷  Try a Trial
D-glucose ⤷  Try a Trial Positive selection Novartis AG (Basel, CH) ⤷  Try a Trial
D-glucose ⤷  Try a Trial Carotenoid ester analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury Cardax Pharmaceuticals, Inc. (Aiea, HI) ⤷  Try a Trial
D-glucose ⤷  Try a Trial Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease Cardax Pharmaceuticals, Inc. (Aiea, HI) ⤷  Try a Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for D-glucose

Drugname Country Document Number Estimated Expiration Related US Patent
D-glucose Australia AU598213 2005-12-06 ⤷  Try a Trial
D-glucose Australia AU6613986 2005-12-06 ⤷  Try a Trial
D-glucose Denmark DK586286 2005-12-06 ⤷  Try a Trial
D-glucose European Patent Office EP0225292 2005-12-06 ⤷  Try a Trial
D-glucose Israel IL80891 2005-12-06 ⤷  Try a Trial
D-glucose Japan JPS62145051 2005-12-06 ⤷  Try a Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Moodys
McKesson
Express Scripts
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.